Literature DB >> 17673134

Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics.

Rebecca M Brotman1, Emily J Erbelding, Roxanne M Jamshidi, Mark A Klebanoff, Jonathan M Zenilman, Khalil G Ghanem.   

Abstract

STUDY
OBJECTIVE: Bacterial vaginosis (BV) is a common infection and has been associated with adverse health outcomes, including preterm birth, pelvic inflammatory disease (PID), and acquisition of HIV. There are limited data on recurrent BV in adolescents. A relationship between the frequency of BV recurrence and specific risk factors might shed light on the pathophysiology of BV and lead to targeted interventions.
DESIGN: Record-based historical clinic study.
SETTING: Adolescent visits to two sexually transmitted disease (STD) clinics between 1990 and 2002. PARTICIPANTS: 254 girls who had >/= 2 episodes of BV and at least 3 clinical visits, matched on clinic attendance frequency to 254 girls with only 1 documented BV episode and 254 girls with no history of BV. MAIN OUTCOME MEASURE: Risk factor differences between groups. ANALYSIS: Multinomial logistic regression with robust estimator of the standard errors, accounting for repeated measures.
RESULTS: 5,977 adolescent girls visited the clinics. 1509 (25%) had at least one episode of BV; of those, 303 (19.9%) had 2 or more BV episodes. Girls with a history of 1 BV episode and girls with a history of 2 or more BV episodes were more likely to be infected with Trichomonas vaginalis [OR 1.77, 95% CI: 1.17-2.67, OR 1.56, 95% CI: 1.05-2.34] and be diagnosed with PID [OR 1.50, 95% CI: 1.02-2.22, OR 2.05, 95% CI: 1.41-2.98] compared to girls with no BV history, respectively. Girls with a history of BV were also more likely to report active oral sex and lack of contraceptive use.
CONCLUSION: Adolescent girls who attend STD clinics have a high prevalence of BV. Although the association between BV and PID is not clearly causal, when one condition is diagnosed, evaluation and counseling for the other may reduce recurrence and sequelae.

Entities:  

Mesh:

Year:  2007        PMID: 17673134      PMCID: PMC3647449          DOI: 10.1016/j.jpag.2006.11.009

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  56 in total

1.  Can known risk factors explain racial differences in the occurrence of bacterial vaginosis?

Authors:  Roberta B Ness; Sharon Hillier; Holly E Richter; David E Soper; Carol Stamm; Debra C Bass; Richard L Sweet; Peter Rice
Journal:  J Natl Med Assoc       Date:  2003-03       Impact factor: 1.798

2.  Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease.

Authors:  Roberta B Ness; Hugh Randall; Holly E Richter; Jeffrey F Peipert; Andrea Montagno; David E Soper; Richard L Sweet; Deborah B Nelson; Diane Schubeck; Susan L Hendrix; Debra C Bass; Kevin E Kip
Journal:  Am J Public Health       Date:  2004-08       Impact factor: 9.308

3.  Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection.

Authors:  Harold C Wiesenfeld; Sharon L Hillier; Marijane A Krohn; Daniel V Landers; Richard L Sweet
Journal:  Clin Infect Dis       Date:  2003-02-07       Impact factor: 9.079

4.  Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation.

Authors:  Jeremy P Burton; Estelle Devillard; Peter A Cadieux; Jo-Anne Hammond; Gregor Reid
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

5.  Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military.

Authors:  Sophia Yen; Mary-Ann Shafer; Jeanne Moncada; Christopher J Campbell; Scott D Flinn; Cherrie B Boyer
Journal:  Obstet Gynecol       Date:  2003-11       Impact factor: 7.661

6.  Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis.

Authors:  Thomas L Cherpes; Leslie A Meyn; Marijane A Krohn; Joel G Lurie; Sharon L Hillier
Journal:  Clin Infect Dis       Date:  2003-07-15       Impact factor: 9.079

Review 7.  Managing recurrent bacterial vaginosis.

Authors:  J Wilson
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519

8.  Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial.

Authors:  Massimo Milani; Eliana Barcellona; Antonella Agnello
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2003-07-01       Impact factor: 2.435

9.  Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis.

Authors:  Rita Verhelst; Hans Verstraelen; Geert Claeys; Gerda Verschraegen; Joris Delanghe; Leen Van Simaey; Catharine De Ganck; Marleen Temmerman; Mario Vaneechoutte
Journal:  BMC Microbiol       Date:  2004-04-21       Impact factor: 3.605

10.  Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis.

Authors:  Michael J Ferris; Alicia Masztal; Kenneth E Aldridge; J Dennis Fortenberry; Paul L Fidel; David H Martin
Journal:  BMC Infect Dis       Date:  2004-02-13       Impact factor: 3.090

View more
  16 in total

Review 1.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Authors:  Rebecca M Brotman
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

2.  Identification of vaginal lactobacilli with potential probiotic properties isolated from women in North Lebanon.

Authors:  Imad Al Kassaa; Monzer Hamze; Didier Hober; Nour-Eddine Chihib; Djamel Drider
Journal:  Microb Ecol       Date:  2014-02-19       Impact factor: 4.552

3.  A mixture of transition models for heterogeneous longitudinal ordinal data: with applications to longitudinal bacterial vaginosis data.

Authors:  Kyeongmi Cheon; Marie E Thoma; Xiangrong Kong; Paul S Albert
Journal:  Stat Med       Date:  2014-03-27       Impact factor: 2.373

4.  Accuracy and trust of self-testing for bacterial vaginosis.

Authors:  Jill S Huppert; Elizabeth A Hesse; Marianne Claire Bernard; Justin R Bates; Charlotte A Gaydos; Jessica A Kahn
Journal:  J Adolesc Health       Date:  2012-03-21       Impact factor: 5.012

5.  Bacterial vaginosis and risk for Trichomonas vaginalis infection: a longitudinal analysis.

Authors:  Sujit D Rathod; Karl Krupp; Jeffrey D Klausner; Anjali Arun; Arthur L Reingold; Purnima Madhivanan
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

6.  The natural history of bacterial vaginosis diagnosed by gram stain among women in Rakai, Uganda.

Authors:  Marie E Thoma; Ronald H Gray; Noah Kiwanuka; Mei-Cheng Wang; Nelson Sewankambo; Maria J Wawer
Journal:  Sex Transm Dis       Date:  2011-11       Impact factor: 2.830

7.  Bacterial Vaginosis and Behavioral Factors Associated With Incident Pelvic Inflammatory Disease in the Longitudinal Study of Vaginal Flora.

Authors:  Rodman Turpin; Susan Tuddenham; Xin He; Mark A Klebanoff; Khalil G Ghanem; Rebecca M Brotman
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 7.759

8.  Behavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trial.

Authors:  Fernand A Guédou; Lut Van Damme; Jennifer Deese; Tania Crucitti; Marissa Becker; Florence Mirembe; Suniti Solomon; Michel Alary
Journal:  BMC Infect Dis       Date:  2013-05-08       Impact factor: 3.090

9.  Simian Immunodeficiency Virus Susceptibility, Immunology, and Microbiome in the Female Genital Tract of Adolescent Versus Adult Pigtail Macaques.

Authors:  Alicia R Berard; Charlene Miller; Mariluz Araínga; Courtney Ann Broedlow; Laura Noël-Romas; Luca Schifanella; Tiffany Hensley-McBain; Alex Roederer; Connor B Driscoll; Ernesto Coronado; Jennifer Manuzak; Lyle R McKinnon; Francois Villinger; Thomas J Hope; Adam D Burgener; Nichole R Klatt
Journal:  AIDS Res Hum Retroviruses       Date:  2021-06-22       Impact factor: 1.723

10.  Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo.

Authors:  Rezvan Zabihollahi; Elahe Motevaseli; Seyed Mehdi Sadat; Ali Reza Azizi-Saraji; Sogol Asaadi-Dalaie; Mohammad Hossein Modarressi
Journal:  Daru       Date:  2012-10-15       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.